David Robin

Title: David Robin: Innovator in Pharmaceutical Chemistry

Introduction

David Robin is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods in drug synthesis. His work has led to the development of a patent that showcases his expertise and creativity in this specialized area.

Latest Patents

David Robin holds a patent for a process titled "Process for making trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine." This patent describes a method for synthesizing trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine and its salts. The method involves the conversion of a compound of formula IVa to the desired compound, showcasing a novel approach in pharmaceutical synthesis.

Career Highlights

David is currently employed at H. Lundbeck A/S, a company renowned for its focus on brain diseases and innovative treatments. His role at Lundbeck allows him to apply his inventive skills in a collaborative environment, contributing to the development of new therapeutic solutions.

Collaborations

David has worked alongside talented colleagues, including Christina Suteu and Christina Wøhlk Nielsen. Their collaborative efforts enhance the innovative atmosphere at H. Lundbeck A/S, fostering advancements in pharmaceutical research.

Conclusion

David Robin's contributions to pharmaceutical chemistry through his patent and work at H. Lundbeck A/S highlight his role as an influential inventor in the industry. His innovative methods continue to pave the way for advancements in drug development.